GlassScriptPhysician profile
Karl E Wolfe
NPI 1013932391
$9,780.01
in general payments reported to CMS, 2019-2025
41 companies · $1,778 in 2025
The $1,778 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,059 · 2022: $2,026 · 2023: $2,040 · 2024: $1,877 · 2025: $1,778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,594 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,594.14 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,487.09 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $779.48 | 2022-2025 | Rexulti |
| Abbvie INC. | $759.14 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $728.81 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $681.68 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $662.48 | 2021-2025 | |
| Glaxosmithkline, LLC. | $651.30 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $410.47 | 2021-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Actelion Pharmaceuticals US, INC. | $374.26 | 2021-2025 | Opsumit, Uptravi |
| Amgen INC. | $351.49 | 2021-2025 | Otezla, Repatha, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $331.52 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $313.82 | 2021-2022 | |
| Lundbeck LLC | $240.07 | 2022-2025 | Rexulti |
| Axsome Therapeutics, INC. | $215.62 | 2025 | Auvelity |
| Nestle Healthcare Nutrition INC. | $206.20 | 2021-2023 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karl Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.